Last 5 Days Trading Activity
|Date||Open Price||Close Price||High||Low||Volume|
Last 5 Days Short Activity
|Date||Short Volume||Total Volume||Short Percentage||Short Indicator|
* Short Mode
About VG Life Sciences Inc. (OTC: VGLS)
About VG Life Sciences Inc. VG Life Sciences Inc., formerly known as Viral Genetics, Inc., is a biotechnology company focused on delivering treatments for patients suffering from autoimmune and chronic inflammatory disorders. Founded in , the company controls over US and international patents and pending patents, protecting its exclusive biotech platform technologies. The company is actively pursuing its custom designed Targeted Peptide Technology for HIV/AIDS and is currently in per clinical animal toxicity studies. The company is also nearing the completion of a Phase I P IND study with its Metabolic Disruption Technology as a promising cancer combination therapy. For more information, visit www.vglifesciences.com, SEC.gov, or find VG Life Sciences Inc. on Facebook, Twitter, and LinkedIn.
- Haig Keledijan / Founder, VP, Legal
- Haig Keledijan / Chairman
- Arthur Keledjian / Arthur Keledjian has served as a member of our Board of Directors since . Mr. Keledjian has been involved with us since our inception and is a valuable addition to our Board of Directors due to his longevity with us and extensive strategic advising experience. Mr. Keledjian is responsible for procuring and managing over million in annual sales with SCI Hispana in his business development role. He is based in Los Angeles, CA. Mr. Keledjian graduated from California State University, Los Angeles with a Bachelor of Science in Business Administration amp Marketing.
Current Share Structure
- Market Cap: $624,298 - 03/09/2018
- Authorized: 170,000,000 - 03/01/2016
- Issue and Outstanding: 112,283,815 - 03/01/2016
- Float: 63,725,893 - 03/01/2016
Daily Technical Chart for (OTC: VGLS)
Stay tuned for daily updates and more on (OTC: VGLS)
More to come on (OTC: VGLS)
Do your DD and if you choose, be ready to go!
The Research: All source information contained in this email is from the public sources mentioned below.
Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in VGLS is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of VGLS and does not buy, sell, or trade any shares of VGLS. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/